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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYTo develop a culture system for large-scale production of mature hepatocytes, liver progenitor cells (LPCs) with a high proliferation po-
tential would be advantageous. We have found that carboxypeptidase M (CPM) is highly expressed in embryonic LPCs, hepatoblasts,
while its expression is decreased along with hepatic maturation. Consistently, CPM expression was transiently induced during hepatic
specification from human-induced pluripotent stem cells (hiPSCs). CPM+ cells isolated from differentiated hiPSCs at the immature he-
patocyte stage proliferated extensively in vitro and expressed a set of genes that were typical of hepatoblasts. Moreover, the CPM+ cells
exhibited a mature hepatocyte phenotype after induction of hepatic maturation and also underwent cholangiocytic differentiation in a
three-dimensional culture system. These results indicated that hiPSC-derived CPM+ cells share the characteristics of LPCs, with the po-
tential to proliferate and differentiate bi-directionally. Thus, CPM is a usefulmarker for isolating hiPSC-derived LPCs, which allows devel-
opment of a large-scale culture system for producing hepatocytes and cholangiocytes.INTRODUCTION
The liver is a central organ for metabolism, and the paren-
chymal cells, or hepatocytes, play key roles for homeostasis
by expressing numerousmetabolic and synthetic enzymes.
As they express a number of cytochrome P450 oxidases
(CYP450s) responsible for the oxidative biotransformation
of many endogenous compounds as well as drugs, primary
cultures of hepatocytes have been used for drug discovery
and toxicology. However, primary hepatocytes exhibit
low metabolic activity in vitro, and the supply of human
hepatocytes is also limited and variable. To overcome these
challenges, human embryonic stem cells (hESCs) and hu-
man-induced pluripotent stem cells (hiPSCs) have been
considered as an alternative cell source for production of
humanhepatocytes. To date, there aremany studies report-
ing hepatic differentiation of hiPSCs/hESCs (Ogawa et al.,
2013; Si-Tayeb et al., 2010; Takayama et al., 2012). How-
ever, in most cases, differentiation of hepatocytes from
hiPSCs is accomplished by a time-consuming culture pro-
tocol with multiple differentiation steps using expensive
cytokines. Also, hepatocytes derived from hiPSCs possess
a limited capacity for proliferation and functional matura-
tion. Thus, it is beneficial to develop a simplified culture
system for large-scale production of mature hepatocytes
from hiPSCs. As liver progenitor cells (LPCs) such as hepa-
toblasts proliferate extensively in vitro, it would be useful if
such cells could be derived from hiPSCs.
The development of the mouse liver begins with early
endoderm development. The cells of the ventral foregut508 Stem Cell Reports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The Aendoderm are induced to the hepatoblast stage by fibro-
blast growth factor (FGF) and bone morphogenetic protein
(BMP) signaling from the heart and septum transversum
mesenchyme (STM). Following induction, hepatoblasts
proliferate and migrate into the STM to form the liver
bud with non-parenchymal cells, such as endothelial pro-
genitor cells and hepatic mesenchymal cells (Zaret and
Grompe, 2008). Importantly, hepatoblasts isolated from
fetal liver can be cultured long-term while maintaining
the potential to differentiate into both hepatocytes and
cholangiocytes, two types of liver epithelial cell (Suzuki
et al., 2000; Tanimizu et al., 2003). LPCs can also be isolated
from normal as well as injured adult livers and maintained
in culture for long term, although their role in vivo remains
elusive (Miyajima et al., 2014).
It has been reported that LPC-like cells were established
from hESCs/hiPSCs (Takayama et al., 2013; Yanagida
et al., 2013; Zhao et al., 2009), and these cells were shown
to proliferate and differentiate into hepatocyte-like
cells or cholangiocyte-like cells. These LPCs were either
isolated by cell sorting using a combination of specific
cell surface markers or generated by adenovirus-mediated
gene transfer to promote hepatic lineage differentiation.
To develop an efficient culture system for large-scale pro-
duction of mature functional hepatocytes, our aim was to
identify a specific cell surface marker for isolating hiPSC-
derived LPCs. In this study, we identified carboxy-
peptidase M (CPM) as a cell surface marker for hepato-
blasts. CPM was also upregulated in hiPSC-derived cells
during hepatic differentiation, and the sorted CPM+ cellsuthors
Figure 1. CPM Expression on Mouse Hep-
atoblasts
(A) FCM analysis of Ba/F3 cells (control)
(left) and Ba/F3 cells expressing CPM
(right). GFP-positive CPM expressing cells
were identified by using the 40-1 antibody.
(B) Localization of CPM (brown) in E14.5
fetal mouse sagittal section.
(C) FCM analysis of mouse fetal liver cells
at E14.5 using antibodies against CPM and
DLK1.
(D) Relative Afp and Alb expression in the
CPM/DLK1neg (), CPM/DLK1low (+) and
CPM/DLK1high (++) fractions as indicated in
(C). n = 1 in each group (each experiment
contains two technical replicates).
(E) RT-PCR analysis shows the expression
of Cpm during mouse liver development
(E11.5, E14.5, E17.5, Neonate, 4 weeks,
8 weeks). The product sizes of Cpm and
Gapdh are 430 bp and 600 bp, respectively.
Amplification of Gapdh was used as an in-
ternal control.
(F) Relative Cpm expression in liver pro-
genitor cells (LPC), Hep (mature hepato-
cytes), and Chol (mature cholangiocytes).
The results are shown as the mean ± SEM
of four independent experiments. (each
experiment contains two technical repli-
cates) ***p < 0.001.
(G) Correlation between the expression of
CPM and the hepatic maturation during liver
development.
See also Figure S1 and Table S1.exhibited features typical of hepatoblasts. Moreover, we
developed a highly efficient and reliable culture system
for hiPSC-derived LPCs capable of proliferating and
differentiating into both hepatocytes and cholangiocytes
in vitro.RESULTS
Identification of CPM as a Hepatoblast Marker
In order to isolate LPCs from hiPSCs effectively, we
searched for cell surface molecules expressed in hepato-
blasts. Although CXCR4 is known to be expressed in hep-
atoblasts, it is also detected in endodermal progenitors,
thus implying that additional markers would be required
to isolate LPCs. DLK1 is an excellent marker for hepato-
blasts and has been extensively used to isolate hepato-
blasts. However, although immunocytochemical stainingStem Cellusing an anti-DLK1 antibody revealed that DLK1-express-
ing cells were present in hiPSC-derived cells at the imma-
ture hepatocyte stage (Figure S1A), flow cytometric (FCM)
analysis showed no expression of DLK1 on the cell surface
(Figure S1B). We therefore searched for other hepatoblast
cell surface molecules. Among 627 monoclonal antibodies
established against mouse fetal liver cells (Suzuki et al.,
2008), we previously found that 40-1 antibody binds to
an unidentified cell surface protein expressed on mouse
hepatoblasts (Tanaka et al., 2009). By employing the
expression cloning procedure, we identified CPM as the
specific antigen for the 40-1 antibody (Figure 1A). Immu-
nohistochemical studies showed that CPM is mainly ex-
pressed in endodermal tissues such as liver, thymus,
lung, and gut in mouse fetus at E14.5 (Figure 1B), con-
firming the previous studies that CPM is widely expressed
in endodermal tissues during mouse development (Tam-
plin et al., 2008).Reports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The Authors 509
Next, we performed FCM analysis/cell sorting to confirm
the expression of CPM in mouse hepatoblasts. CPM was
coexpressed with a hepatoblast marker, DLK, and CPM+
cells isolated from E14.5 fetal liver also highly expressed
LPCmarkers such as alpha-1-fetoprotein (Afp) and albumin
(Alb) (Figures 1C and 1D). Cpm was highly expressed in
fetal liver, but its expression was dramatically decreased af-
ter birth (Figure 1E) and was undetectable in mature hepa-
tocytes and cholangiocytes (Figure 1F). Collectively, these
data demonstrated that CPM is strongly expressed in hep-
atoblasts and fetal LPCs (Figure 1G) and also suggested
that CPM may be a useful marker for enrichment of LPCs
from differentiating hiPSCs.
CPM Expression during Hepatic Differentiation from
Human iPSCs
To evaluate whether CPM could be used as a marker for
enrichment of LPCs from hiPSCs, we first analyzed the
expression levels of CPM in human fetal liver. CPM was
highly expressed in human fetal liver from 6 to 12 weeks
of gestation, but was expressed at very low levels in adult
liver and HepG2 cells, a human hepatocellular carcinoma
cell line (Figure 2A). We then examined the CPM expres-
sion profile during hepatic differentiation from hiPSCs
by qRT-PCR and FCM analysis. As described in the pre-
viously reported protocol, we induced hepatic differenti-
ation in two hiPSC lines (454E2 and 409B2). hiPSCs
showed morphological changes after induction toward
the hepatic lineage (Figure S2A), with rapid downregula-
tion of OCT4 and sequential induction of GATA4,
SOX17, FOXA2, and HNF4a (Figures S2B and S2C).
In this culture system, the expression level of CPM was
undetectable in undifferentiated hiPSCs, but upregulated
together with hepatic progenitor markers such as FOXA2
and HNF4a during differentiation (Figures 2B, S2B, and
S2C). FCM analysis revealed that 20% of specified hepatic
cells were CPM+, with this population increasing to
40% after differentiation to immature hepatocytes.
CPM expression decreased along with subsequent hepatic
maturation (Figure 2C). Collectively, these data showed
that CPM is a specific cell surface marker for human
iPSC-derived LPCs.
Enrichment of hiPSC-Derived LPCs Based on the
Expression of CPM
To further characterize the CPM+ cells derived fromhiPSCs,
we used a magnetic cell sorter to isolate the cells of interest
and established a culture system to expand them. The pu-
rity of enriched CPM+ cells was over 97% after isolation
by single step sorting using a magnetic cell sorter (Fig-
ure 2D). CPM+ cells formed compact colonies on MEF
feeder cells and exhibited epithelial-like morphology,
whereas no such colonies were formed from CPM cells510 Stem Cell Reports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The A(Figure 2E). CPM+ cells exhibited a high proliferative
capacity and grew to confluence by day 7 after seeding
(Figure 2F). These cells continued to expand after several
passages in vitro (Figure 2G). Immunocytochemistry
demonstrated that all CPM+ cells strongly expressed AFP
and HNF4a, a key transcription factor for LPCs (Figure 2E).
These cells could also be cultured even after several pas-
sages (Figure S2D) or cryopreservation (Figure S2E). In addi-
tion to AFP and HNF4a, hepatoblast markers HNF1a,
PROX1, TBX3,CD13, EpCAM, andHHEXwere significantly
enriched in CPM+ cells compared with CPM cells (Fig-
ure 2H). In contrast, CD133, a cholangiocyte marker, was
significantly expressed in CPM cells. All these data
strongly suggested that CPM is a useful cell surface marker
to enrich for LPCs in hiPSC-derived immature hepatic
cells. Similar results were obtained from a different hiPSC
line (409B2) (Figure S2F), indicating that the efficiency of
our method for generating CPM+ LPCs is not cell line-
dependent.
Differentiation of Hepatocytes and Cholangiocytes
from CPM+ LPCs
It is well established that LPCs differentiate into both
hepatocytes and cholangiocytes. Therefore, we evaluated
the differentiation potential of CPM+ LPCs. After expan-
sion of the CPM+ population by serial passages on MEF
feeder cells, these cells were then differentiated into he-
patocytes by addition of Oncostatin M (Figure 3A). As
shown in Figure 3B, the hepatocytes from CPM+ LPCs
showed typical human primary hepatocyte morphology,
with binuclear cells delineated distinctly by bright bor-
ders. In addition, these cells exhibited high level ex-
pression of ALB, accumulation of glycogen and uptake
of Dil-Ac-LDL (Figures 3C–3E), indicative of mature
hepatocytes. FCM analysis showed that almost all differ-
entiated cells expressed ALB (Figure S3A). The levels of
hepatic gene expression such as CYP3A4, CYP2C19,
CYP2C18, CYP2D6, CYP1A2, and CYP2C8 in hepato-
cyte-like cells derived from CPM+ LPCs were much
higher than those derived from hiPSCs by the conven-
tional differentiation protocol (Figure 3F). Furthermore,
hepatocytes derived from CPM+ LPCs secreted high
amounts of ALB and urea into the culture medium (Fig-
ure 3G) and exhibited high CYP3A4 activity (Figure 3H).
In addition, CYP3A4 activity was significantly induced in
response to rifampicin treatment, which is a well-known
CYP3A4 inducer (Figure 3H). Collectively, hepatocytes
derived from CPM+ cells exhibited higher metabolic
activity compared to those derived from hiPSCs using a
conventional protocol.
Furthermore, CPM+ LPCs were converted to cholangio-
cytes, which formed cysts with the luminal structure
in vitro after culturing in a gel consisting of collagenuthors
Figure 2. Enrichment of the hiPSC-Derived LPCs Based on the Expression of CPM
(A) Relative CPM expression in HepG2 cells and liver tissues (adult liver, gestational ages: 6 weeks, 8 weeks, 12 weeks). n = 1 in each group
(each experiment contains two technical replicates).
(legend continued on next page)
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Figure 3. Differentiation of Hepatocytes
from hiPSC-Derived CPM+ LPCs
(A) Schematic image of hepatocyte-like cell
differentiation from CPM+ LPCs.
(B–D) The morphology of CPM+ LPCs (upper)
and CPM+ hepatocyte-like cells (lower)
was investigated by microcopy. (B) Phase
contrast images. CPM+ LPCs exhibit light
cytoplasm and indistinct cell borders. CPM+
hepatocyte-like cells exhibit cobblestone-
like morphology with binucleation. (C)
Immunohistochemistry for AFP (red), ALB
(green) and HNF4a (gray). Nuclei were
counterstained with Hoechst 33342 (blue).
(D) PAS staining showed accumulation of
glycogen. Scale bars, 100 mm.
(E) Uptake of DilAcLDL (red) in CPM+ hepa-
tocyte-like cells. Scale bar, 100 mm.
(F) qRT-PCR analysis of various CYP450s
mRNA levels. The results are shown as
the mean ± SEM of six independent ex-
periments. (each experiment contains two
technical replicates). iPSC-Heps was used as
a control. *p < 0.05, **p < 0.01, ***p <
0.001.
(G) Secretion of ALB and urea. The results
are shown as the mean ± SEM of seven in-
dependent experiments. iPSC-Heps was used
as a control. *p < 0.05, **p < 0.01, ***p <
0.001.
(H) Relative CYP3A4 activity. The results are
shown as the mean ± SEM of at least three
independent experiments. Treatment with
10 mM of rifampicin (Rif) for 72 hr. iPSC-
Heps was used as a control. *p < 0.05, **p <
0.01, ***p < 0.001.
See also Figure S3 and Tables S1 and S2.and Matrigel (Figures 4A, 4B, S4A, and S4B). The ex-
pression of AFP was dramatically decreased after differ-
entiation (Figure 4C). Moreover, immunohistochemistry(B and C) CPM mRNA and protein expression were analyzed by qRT-P
specified hepatic; IH, immature hepatocytes; MH, mature hepatocytes
experiments. *p < 0.05 between iPSCs and IH, **p < 0.01 between iP
(D) FCM analysis of CPM expression was performed in pre- and post-s
(E) Morphology of the CPM+ cells (left upper) and CPM cells (left lo
histochemical staining for AFP (green) and HNF4a (red) in CPM+ cells (
Hoechst 33342 staining (blue). Scale bar, 100 mm.
(F) Growth curve of CPM+ cells. Each value was determined in triplica
periments.
(G) Relative cell number after several passages. Error bar represents t
(H) Expression of hepatoblast markers in CPM+ cells compared with CPM
as the mean ± SEM of eight independent experiments. (each experim
See also Tables S1and S2.
512 Stem Cell Reports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The Ashowed that F-actin, PKC, and AQP1 localized to the api-
cal membrane, whereas CD49f was detected in the baso-
lateral membrane in cystic cells (Figures 4D–4F), thusCR (B) and FCM (C). iPSCs, iPS cells; DE, definitive endoderm; SH,
. For (B), error bar represents the mean ± SEM of three independent
SCs and MH. See also Figures S2B and S2C.
orted cells.
wer) on MEF feeder cells. Cells were cultured for 4 days. Immuno-
right upper) and CPM cells (right lower). Nuclei were visualized by
te. Error bar represents the mean ± SEM of three independent ex-
he mean ± SEM of four independent experiments.
 cells. *p < 0.05, **p < 0.01, ***p < 0.001. The results are shown
ent contains two technical replicates).
uthors
Figure 4. Differentiation of Cholangiocytes from hiPSC-
Derived CPM+ LPCs
(A) Schematic image of cholangiocyte-like cells differentiation
from CPM+ LPCs.
(B) Phase contrast image. CPM+ LPCs form cysts in collagen/Ma-
trigel after 7 days of culture. See also Figures S4A and S4B.
(C) Expression of AFP in CPM+ LPCs and CPM+ cholangiocytes. The
results are shown as the mean ± SEM of four independent experi-
ments (each experiment contains two technical replicates). **p <
0.01.
(D–F) Immunofluorescence staining for cholangiocyte markers in
CPM+ cholangiocyte-like cells. Localization of (D) CK7 (red), F-actin
(green), (E) CD49f (red), PKC (green), (F) b-catenin (red), AQP1
(green). Nuclei were visualized by Hoechst 33342 staining (blue).
Scale bars, 100 mm.
(G) Gene expression profile of CPM+ cholangiocyte-like cells
compared with iPSC cholangiocyte-like cells. The results are shown
as the mean ± SEM of four independent experiments (each exper-
iment contains two technical replicates). ND, not detected. **p <
0.01, ***p < 0.001.
See also Tables S1 and S2.showing the proper apico-basal structure. In this culture
system, cells derived from CPM+ LPCs highly expressed
cholangiocyte marker genes, such as CK7, CFTR, AQP1,
TGR5, SOX9, and HNF6, compared with iPSC-derived
cholangiocytes (without CPM purification process) (Fig-Stem Cellure 4G). These results indicate that CPM+ LPCs can differ-
entiate into both hepatocyte-like cells and cholangiocyte-
like cells.DISCUSSION
Generation of mature hepatocytes and cholangiocytes
from iPS/ES cells requires time-consuming multiple pro-
cesses with expensive cytokines. Therefore, it would
be beneficial to derive expandable precursor cells to
simplify the procedure. Because LPCs are able to prolifer-
ate extensively in vitro and differentiate to both hepato-
cytes and cholangiocytes (Suzuki et al., 2000; Tanimizu
et al., 2003, 2007), they are ideal cells to use in devel-
oping an efficient protocol for large-scale production of
mature liver cells. In order to isolate LPCs, we first tested
the expression of DLK1 and CXCR4, which are well
known to be expressed in hepatoblasts. However, neither
of these markers was appropriate for enriching LPCs
from hiPSC-derived cells, as described above. We there-
fore searched for another marker and showed that CPM
is a cell surface antigen expressed on hepatoblasts in
mouse fetal liver between E11.5 and E17.5, although its
expression is dramatically downregulated in mature he-
patocytes and cholangiocytes. CPM is a member of the
carboxypeptidase family, expressed on the cell surface
to catalyze the release of C-terminal arginine or lysine
residues of peptides and proteins (Skidgel et al., 1989).
While its role in hepatoblasts is currently unknown, we
found that the expression of CPM was gradually upregu-
lated along with hepatic differentiation from hiPSC-
like liver development. The simple method of single
step cell sorting based on CPM expression made it
possible to enrich the LPC fraction after induction of
hiPSCs to the immature hepatocyte stage. These CPM+
cells exhibited a high proliferative potential and the
expanded cells could be cryopreserved. Moreover, they
expressed various liver progenitor markers (Figure 2H).
While most CPM+ cells expressed HNF4a (Figure 2E),
expression of midgut/hindgut markers such as CDX2
and PDX1 was also detected by RT-PCR (data not shown),
suggesting that CPM+ cells may contain non-liver pro-
genitors. However, after induction of hepatic differentia-
tion, almost all cells became hepatocytes as shown by
their morphology and ALB expression (Figures 3B, 3C,
and S3A). If such non-hepatic progenitors were present
in the CPM+ cells, they did not affect hepatocyte
differentiation.
CPM+ LPCs were able to differentiate in a single step
culture to either hepatocyte-like cells or cholangiocyte-
like cells depending on the culture condition. Further-
more, hepatocytes derived from CPM+ cells exhibited aReports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The Authors 513
significantly higher level of metabolic activity compared
to the hiPSC-derived hepatocytes using a conventional
differentiation protocol. Importantly, these hepatocyte-
like cells remain phenotypically stable for more than
2 weeks (Figure S3B). Thus, CPM+ LPCs derived from
hiPSCs will be useful for developing a reliable long-term
hepatocyte culture system, and this simplified purification
method will contribute to basic and clinical research
related to liver diseases. Although CPM+ hepatocytes
highly expressed mature hepatic genes involved in gluco-
genesis (G6PC, PCK1) and the urea cycling (CPS1), they ex-
hibited variable levels of CYP expression compared with
cultured primary human hepatocytes (Figure S3C). It is
well known that the capacity to metabolize drugs is vari-
able due to genetic polymorphisms in CYPs (Ingelman-
Sundberg et al., 2007). Hepatocyte-like cells differentiated
from iPSCs are highly variable due to retention of donor-
specific metabolic capacity (Takayama et al., 2014), sug-
gesting that the expression of CYPs in CPM+ Hepatocytes
may be affected by a donor’s genetic background.
Because freshly isolated hepatocytes rapidly lose their
functions, it is amajor challenge to generate fully functional
hepatocytes from pluripotent stem cells. While hepatocytes
derived fromCPM+ LPCs expressed high levels of metabolic
activity, the levels of some proteins are not as high as
primary human hepatocytes and there is still room for
improvement. During embryogenesis, hepatoblasts differ-
entiate into mature hepatocytes through interactions with
non-parenchymal cells. As non-parenchymal cells are in
direct contact with hepatoblasts and also produce various
cytokines to induce hepatic maturation, co-culture of
CPM+ hepatocytes with non-parenchymal cells may be an
effective way to generate more mature hepatocytes from
hiPSCs, and we are currently investigating this possibility.EXPERIMENTAL PROCEDURES
Cell Culture
Two hiPSC lines (454E2 and 409B2) were provided by RIKEN Cell
Bank (Okita et al., 2011). These cells were maintained on mito-
mycin C-treated (Wako Pure Chemical Industries) mouse embry-
onic fibroblast (MEF) feeder cells, and hepatic differentiation of
hiPSCs was induced using the four-step protocol previously re-
ported, with minor modifications (Si-Tayeb et al., 2010).Isolation and Expansion of LPCs Derived from hiPSCs
After induction of hiPSCs to the immature hepatocyte stage, cells
were sorted using aMoFloXDP cell sorter (BeckmanCoulter) or au-
toMACS Pro Separator (Miltenyi Biotech) into CPM+ and CPM
populations. To expand hiPSC-derived CPM+ cells, we modified
the published method (Chen et al., 2007; Huch et al., 2013; Yana-
gida et al., 2013) as follows: sorted cells were cultured on mito-
mycin c-treated MEF feeder cells (2.0 3 104 cells/cm2) in DMEM-514 Stem Cell Reports j Vol. 5 j 508–515 j October 13, 2015 j ª2015 The AF12 (Sigma-Aldrich) supplemented with 10% FBS (JRH Biosci-
ences), penicillin-streptomycin-glutamine, ITS, N-2 supplement,
MEM non-essential amino acids solution, L-glutamine (Life Tech-
nologies), ascorbic acid (1 mM), nicotinamide (10 mM), N-acetyl-
cysteine (0.2 mM) (Sigma-Aldrich), dexamethasone (1 3 107
M), HGF (20 ng/ml), EGF (10 ng/ml) (PeproTech), Y-27632
(5 mM) (Wako), and A83-01 (2.5 mM) (Tocris).
Differentiation of Hepatocytes and Cholangiocytes
from CPM+ LPCs
To induce hepatic maturation of CPM+ LPCs, confluent cells
were incubated in Hepatocyte Basal Medium (Lonza) supple-
mented with HCM SingleQuots (excluding EGF) and Oncostatin
M (20 ng/ml) (PeproTech) for 5–10 days as described previously
(Si-Tayeb et al., 2010). Induction of cholangiocyte differentia-
tion was performed using the three-dimensional gel culture
method previously reported (Tanimizu et al., 2007; Yanagida
et al., 2013) with minor modifications. After expansion of
CPM+ LPCs, the resulting cells were collected and re-suspended
in a gel composed of 2:3 mixture of growth factor reduced Ma-
trigel (Corning) and collagen type I (Nitta Gelatin) at a density
of 1 3 105 cells/50 ml. Cell suspensions were then added to a
24-well plate (Corning) and incubated for 2 hr at 37C until
solidification. The cells were then cultured in the presence of
R-spondin-1 (40 ng/ml) and WNT-3a (40 ng/ml) (PeproTech)
for 7 days.
Additional details of experimental procedures are available in the
Supplemental Information.
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